Aurobindo Pharma informs about analyst meet

04 Mar 2022 Evaluate
Aurobindo Pharma has informed that S. Subramanian, Chief Financial Officer of the Company, will be participating in virtual event of Goldman Sachs India Pharma and Healthcare Tour 2022 on March 7, 2022. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. 

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1401.10 5.10 (0.37%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.